This treatment approach was based on a better understanding of the basic biology in particular of clear cell RCC (ccRCC), which commonly harbors an inactivation of the VHL gene and deregulation of the HIF/VEGF transcriptional network (3). The gene discussed is VEGFA; the disease is nonpapillary renal cell carcinoma.